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Shua J. Chai, Feng Tan, Yongcai Ji, Xiaomin Wei, Richun Li, and Melinda Frost. “Community-Level 
Text Messaging for 2009 H1N1 Prevention in China.” American Journal of Preventive Medicine, 2013, 
45: 190-6. 
  
This study aims to determine the effectiveness of mobile phone text messaging (SMS) in improving 
2009 H1N1 knowledge, attitudes, behaviors, and self-reported outcomes and to assess community 
SMS acceptability. A program evaluation of Shanghai, China's SMS system using a single-blinded, 
randomized-controlled method was conducted in 2010. Randomly selected community residents 
who agreed to participate were assigned to receive 3 weeks of either 2009 H1N1 prevention and 
control or tobacco-cessation messages. It finds that of 1992 respondents, those receiving 2009 H1N1 
messages had higher scores measuring 2009 H1N1 knowledge and desired attitudes (p<0.001); 1.77 
times greater odds of new 2009 H1N1 vaccination (p<0.001); and 0.12 times smaller odds of 
reporting influenza-like illness (p<0.001) than those receiving tobacco messages. This study 
concludes that SMS can improve self-reported uptake of short-term behaviors, such as vaccination, 
that can result in long-term prevention and control of disease. SMS can improve knowledge and 
influence attitudes about infection prevention and control and self-reported health outcomes.  
 
Xian Qi, Yan-Hua Qian, Chang-Jun Bao, Xi-Ling Guo, Lun-Biao Cui, Fen-Yang Tang, Hong Ji, Yong 
Huang, Pei-Quan Cai, Bing Lu, Ke Xu, Chao Shi, Feng-Cai Zhu, Ming Hao Zhou, and Hua Wang. 
“Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 
2013: epidemiological investigation.” BMJ, 2013, 347 doi: http://dx.doi.org/10.1136/bmj.f4752. 
 
This study aimed to determine whether the novel avian influenza H7N9 virus can transmit from 
person to person and its efficiency. Samples from the two patients with avian H7N9 in Wuxi, China in 
March 2013 and environments were collected and tested by real time reverse transcriptase-
polymerase chain reaction (rRT-PCR), viral culture, and haemagglutination inhibition assay. The 
index patient became ill five to six days after his last exposure to poultry. The second patient, his 
daughter aged 32, who provided unprotected bedside care in the hospital, had no known 
exposure to poultry. She developed symptoms six days after her last contact with her father. Two 
strains were isolated successfully from the two patients. Genome sequence and analyses of 
phylogenetic trees showed that both viruses were almost genetically identical. Forty three close 
contacts of both patients were identified. One had mild illness but had negative results for avian 
H7N9 by rRT-PCR. All 43 close contacts tested negative for haemagglutination inhibition antibodies 
specific for avian H7N9. This study concluded that the infection of the daughter probably resulted 
from contact with her father (the index patient) during unprotected exposure, suggesting that in 
this cluster the virus was able to transmit from person to person. The transmissibility was limited and 
non-sustainable. 
 
Xiuxiu Zhao, Ping Yang, Ruoyan Gai, Lin Mei, Xingzhou Wang, and Lingzhong Xu. “Determinants of 
health care-seeking delay among tuberculosis patients in Shandong Province, China.” European 
Journal of Public Health, Advance Access, 10.1093/eurpub/ckt113. 
 
This study aimed to understand the situation of initial health care-seeking delay among tuberculosis 
patients in eastern China, and explore its influencing factors, to provide a basis for formulating 
related polices and reducing its transmission. A cross-sectional survey was conducted in six counties 
of Shandong Province, China and the study sites were selected by multi-stage random sampling. 
Subjects were pulmonary tuberculosis patients registered with the county tuberculosis dispensaries 
at study sites that completed treatment during the period October 2006 to September 30, 2007. For 
the 819 cases of pulmonary tuberculosis, the median initial health care-seeking delay time was 6 
days, and 49.8% of them were initial health care-seeking delayed. The logistic regression analysis 
showed that marriage (odds ratio = 0.354, 95% CI: 0.193–0.650) and knowledge of the national 
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tuberculosis subsidy policy (odds ratio = 1.753, 95% CI: 1.258–2.441) were associated with initial 
health care-seeking delay. This study concluded that changing the perception of patients and 
popularizing the national tuberculosis subsidy policy would do well towards reducing initial health 
care-seeking delay. 
 
Zhiyuan Hou, Ellen Van de Poel, Eddy Van Doorslaer, Baorong Yu, and Qingyue Meng. Effects of 
NCMS on access to care and financial protection in China. Health Economics, Early View, DOI: 
10.1002/hec.2965. 
 
The introduction of the New Cooperative Medical Scheme (NCMS) in rural China has been the 
most rapid and dramatic extension of health insurance coverage in the developing world in this 
millennium. The literature to date has mainly used the uneven rollout of NCMS across counties as a 
way of identifying its effects on access to care and financial protection. This study exploits the cross-
county variation in NCMS generosity in 2006 and 2008 in the Ningxia and Shandong provinces to 
estimate the effect of coverage generosity on utilization and financial protection. The results 
confirm earlier findings of NCMS being effective in increasing access to care but not in increasing 
financial protection. In addition, this study finds NCMS enrollees to be sensitive to the price 
incentives set in the NCMS design when choosing their provider and providers to respond by 
increasing prices and/or providing more expensive care. 
 
Lindsay M Jaacks, Penny Gordon-Larsen, Elizabeth J Mayer-Davis, Linda S Adair, and Barry Popkin. 
“Age, Period and Cohort Effects on Adult Body Mass Index and Overweight from 1991 to 2009 in 
China: the China Health and Nutrition Survey.” International Journal of Epidemiology, 2013, 42: 828-
37. 
 
The authors collected data from the China Health and Nutrition Survey from 1991 to 2009 which 
included 53,298 observations from 18,059 participants across nine provinces in China. They used 
mixed effects models to explicitly assess differences in body mass index (BMI) within individuals over 
time (age effect) and population-wide differences in BMI over time (period effect), and implicitly 
assess differences in the experienced period effect across individuals of varying ages (cohort 
effect). Stronger period effects on BMI and overweight were observed among males compared 
with females; and younger cohorts had higher BMIs compared with older cohorts. The authors 
concluded that although period effects had a stronger influence on the BMI of males, interventions 
should not overlook younger female cohorts who are at increased risk compared with their older 
counterparts. 
 
Jiu-Yao Wang, Li-Fan Liu, Chuan-Yu Chen, Ya-Wen Huang, Chao A Hsiung, and Hui-Ju Tsai. 
“Acetaminophen and/or antibiotic use in early life and the development of childhood allergic 
diseases.” International Journal of Epidemiology, 2013, 42: 1087-99. 
 
The authors conducted a prospective birth cohort study of 263,620 children born in 1998 and 9,910 
children born in 2003, separately, from the National Health Insurance Research Database (NHIRD) in 
Taiwan. Exposure status of acetaminophen and/or antibiotics and potential confounding factors 
were included in the analyses. Cox proportional hazards models were applied to determine the 
temporal relationship between acetaminophen and/or antibiotic exposure and the development 
of allergic diseases. They observed a positive relationship between acetaminophen and/or 
antibiotic exposure during the 1st year of life and the subsequent development of the three 
examined allergic diseases (atopic dermatitis, asthma and allergic rhinitis) in the 1998 birth cohort, 
but the observed relationship of drug exposure in the 2003 cohort, especially for atopic dermatitis 
and asthma, was lower than for those in the 1998 cohort and was not statistically significant. The 
authors concluded that the temporal effect of exposure to acetaminophen and/or antibiotics 




Zhongliang Zhou, Yanfang Su, Jianmin Gao, Benjamin Campbell, Zhengwei Zhu, Ling Xu, Yaoguang 
Zhang. “Assessing equity of healthcare utilization in rural China: results from nationally 
representative surveys from 1993 to 2008.” International Journal for Equity in Health, 2013, 12:34.   
 
The authors estimated need-predicted healthcare utilization of outpatient and inpatient services 
using the National Health Service Survey (NHSS) in 1993, 1998, 2003, and 2008. Need-standardized 
healthcare utilization is assessed through indirect standardization method. Concentration index is 
measured to reflect income-related inequity of healthcare utilization. They found that the 
concentration index of need-standardized outpatient utilization is 0.0486[95% CI (0.0399, 0.0574)], 
0.0310[95% CI (0.0229, 0.0390)], 0.0167[95% CI (0.0069, 0.0264)] and −0.0108 [95% CI (−0.0213, -
0.0004)] in 1993, 1998, 2003 and 2008, respectively. For inpatient service, the concentration index is 
0.0529[95% CI (0.0349, 0.0709)], 0.1543[95% CI (0.1356, 0.1730)], 0.2325[95% CI (0.2132, 0.2518)] and 
0.1313[95% CI (0.1174, 0.1451)] in 1993, 1998, 2003 and 2008, respectively. The authors concluded 
that utilization of both outpatient and inpatient services was pro-rich in rural China with the 
exception of outpatient service in 2008. With the same needs for healthcare, rich rural residents 
utilized more healthcare service than poor rural residents. Compared to utilization of outpatient 
service, utilization of inpatient service was more inequitable. Inequity of utilization of outpatient 
service reduced gradually from 1993 to 2008; meanwhile, inequity of inpatient service utilization 
increased dramatically from 1993 to 2003 and decreased significantly from 2003 to 2008.  
 
Yu Xu, Limin Wang, Jiang He, Yufang Bi, Mian Li, Tiange Wang, Linhong Wang, Yong Jiang, Meng 
Dai, Jieli Lu, Min Xu, Yichong Li, Nan Hu, Jianhong Li, Shengquan Mi, Chung-Shiuan Chen, 
Guangwei Li, Yiming Mu, Jiajun Zhao, Lingzhi Kong, Jialun Chen, Shenghan Lai, Weiqing Wang, 
Wenhua Zhao, and Guang Ning. “Prevalence and Control of Diabetes in Chinese Adults.” JAMA, 
2013, 310: 948-959.  
 
The authors conducted a cross-sectional survey in a nationally representative sample of 98,658 
Chinese adults in 2010 using a complex, multistage, probability sampling design. Plasma glucose 
and hemoglobin A1c levels were measured after at least a 10-hour overnight fast among all study 
participants, and a 2-hour oral glucose tolerance test was conducted among participants without 
a self-reported history of diagnosed diabetes. They estimated that the overall prevalence of 
diabetes was 11.6% (95% CI, 11.3%-11.8%) in the Chinese adult population. The prevalence among 
men was 12.1% (95% CI, 11.7%-12.5%) and among women was 11.0% (95% CI, 10.7%-11.4%). The 
prevalence of previously diagnosed diabetes was estimated to be 3.5% (95% CI, 3.4%-3.6%) in the 
Chinese population: 3.6% (95% CI, 3.4%-3.8%) in men and 3.4% (95% CI, 3.2%-3.5%) in women. The 
prevalence of undiagnosed diabetes was 8.1% (95% CI, 7.9%-8.3%) in the Chinese population: 8.5% 
(95% CI, 8.2%-8.8%) in men and 7.7% (95% CI, 7.4%-8.0%) in women. In addition, the prevalence of 
prediabetes was estimated to be 50.1% (95% CI, 49.7%-50.6%) in Chinese adults: 52.1% (95% CI, 
51.5%-52.7%) in men and 48.1% (95% CI, 47.6%-48.7%) in women. The prevalence of diabetes was 
higher in older age groups, in urban residents, and in persons living in economically developed 
regions. Among patients with diabetes, only 25.8% (95% CI, 24.9%-26.8%) received treatment for 
diabetes, and only 39.7% (95% CI, 37.6%-41.8%) of those treated had adequate glycemic control. 
The authors projected that there were up to 113.9 million Chinese adults with diabetes and 493.4 
million with prediabetes. These findings indicate the importance of diabetes as a public health 
problem in China. 
 
Gonghuan Yang, Yu Wang, Yixin Zeng, George F Gao, Xiaofeng Liang, Maigeng Zhou, Xia Wan, 
Shicheng Yu, Yuhong Jiang, Mohsen Naghavi, Theo Vos, Haidong Wang, Alan D Lopez, and 
Christopher JL Murray. “Rapid health transition in China, 1990–2010: findings from the Global Burden 
of Disease Study 2010.” The Lancet, 2013, 381:1987-2015.  
 
The authors used results of the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 
2010) for 1990 and 2010 for China and 18 other countries in the G20 to assess rates and trends in 
mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted 
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life-years (DALYs), and healthy life expectancy (HALE). They presented results for 231 diseases and 
injuries and for 67 risk factors or clusters of risk factors relevant to China and assessed relative 
performance of China against G20 countries. They found that the leading causes of death in China 
in 2010 were stroke (1.7 million deaths, 95% uncertainty intervals (UI) 1.5 − 1.8 million), ischaemic 
heart disease (948,700 deaths, 774, 500 – 1,024,600), and chronic obstructive pulmonary disease 
(934,000 deaths, 846,600 − 1,032,300). Age-standardised YLLs in China were lower in 2010 than all 
emerging economies in the G20, and only slightly higher than noted in the USA. China had the 
lowest age-standardised YLD rate in the G20 in 2010. China also ranked tenth (95% UI eighth to 
tenth) for HALE and 12th (11th to 13th) for life expectancy. YLLs from neonatal causes, infectious 
diseases, and injuries in children declined substantially between 1990 and 2010. Mental and 
behavioural disorders, substance use disorders, and musculoskeletal disorders were responsible for 
almost half of all YLDs. The fraction of DALYs from YLDs rose from 28·1% (95% UI 24·2—32·5) in 1990 to 
39·4% (34·9—43·8) in 2010. Leading causes of DALYs in 2010 were cardiovascular diseases (stroke 
and ischaemic heart disease), cancers (lung and liver cancer), low back pain, and depression. 
Dietary risk factors, high blood pressure, and tobacco exposure are the risk factors that constituted 
the largest number of attributable DALYs in China. Ambient air pollution ranked fourth (third to fifth; 
the second highest in the G20) and household air pollution ranked fifth (fourth to sixth; the third 
highest in the G20) in terms of the age-standardised DALY rate in 2010. 
 
Kit Yee Chan, Wei Wang, Jing Jing Wu, Li Liu, Evropi Theodoratou, Josip Car, Lefkos Middleton, Tom 
C Russ, Ian J Deary, Harry Campbell, Wei Wang, and Igor Rudan. “Epidemiology of Alzheimer's 
disease and other forms of dementia in China, 1990–2010: a systematic review and analysis.” The 
Lancet, 2013, 381: 2016-23. 
 
The authors searched for reports of Alzheimer's disease or dementia in China, published in Chinese 
and English between 1990 and 2010 from the databases of National Knowledge Infrastructure, 
Wanfang, and PubMed. They found 12 642 reports, of which 89 met the inclusion criteria (75 
assessed prevalence, 13 incidence, and nine mortality). In total, the included studies had 340,247 
participants, in which 6357 cases of Alzheimer's disease were recorded. 254,367 people were 
assessed for other forms of dementia, of whom 3,543 had vascular dementia, frontotemporal 
dementia, or Lewy body dementia. In 1990 the prevalence of all forms of dementia was 1.8% (95% 
CI 0.0 – 44.4) at 65 − 69 years, and 42.1% (0.0 – 88.9) at age 95 − 99 years. In 2010 prevalence was 
2.6% (0.0 – 28.2) at age 65 − 69 years and 60.5% (39.7 − 81.3) at age 95 − 99 years. The number of 
people with dementia in China was 3.68 million (95% CI 2.22 – 5.14) in 1990, 5.62 million (4.42 − 6.82) 
in 2000, and 9.19 million (5.92 − 12.48) in 2010. In the same period, the number of people with 
Alzheimer's disease was 1.93 million (1.15 − 2.71) in 1990, 3.71 million (2.84 – 4.58) people in 2000, and 
5.69 million (3.85 − 7.53) in 2010. The incidence of dementia was 9.87 cases per 1000 person-years, 
that of Alzheimer's disease was 6.25 cases per 1000 person-years, that of vascular dementia was 
2.42 cases per 1000 person-years, and that of other rare forms of dementia was 0.46 cases per 1000 
person-years. They retrieved mortality data for 1,032 people with dementia and 20,157 healthy 
controls, who were followed up for 3 − 7 years. The median standardised mortality ratio was 1.94:1 
(IQR 1·74 − 2·45). The authors concluded that the burden of dementia seems to be increasing faster 
than is generally assumed by the international health community. Rapid and effective government 
responses are needed to tackle dementia in low-income and middle-income countries. 
 
Feng-Cai Zhu, Fan-Yue Meng, Jing-Xin Li, Xiu-Ling Li, Qun-Ying Mao, Hong Tao, Yun-Tao Zhang, Xin 
Yao, Kai Chu, Qing-Hua Chen, Yue-Mei Hu, Xing Wu, Pei Liu, Lin-Yang Zhu, Fan Gao, Hui Jin, Yi-Juan 
Chen, Yu-Ying Dong, Yong-Chun Liang, Nian-Min Shi, Heng-Ming Ge, Lin Liu, Sheng-Gen Chen, Xing 
Ai, Zhen-Yu Zhang, Yu-Guo Ji, Feng-Ji Luo, Xiao-Qin Chen, Ya Zhang, Li-Wen Zhu, Zheng-Lun Liang, 
and Xin-Liang Shen. “Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 
71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, 




The authors assessed the efficacy, safety, immunogenicity, antibody persistence, and 
immunological correlates of an inactivated alum-adjuvant enterovirus 71 (EV71) vaccine. They did 
a randomised, double-blind, placebo-controlled, phase 3 trial. Healthy children aged 6—35 months 
from four centres in China were randomly assigned (1:1) to receive vaccine or alum-adjuvant 
placebo at day 0 and 28, according to a randomisation list (block size 30) generated by an 
independent statistician. Investigators and participants and their guardians were masked to the 
assignment. Primary endpoints were EV71-associated hand, foot, and mouth disease (HFMD) and 
EV71-associated disease during the surveillance period from day 56 to month 14, analysed in the 
per-protocol population. 10,245 participants were enrolled and assigned: 5,120 to vaccine versus 
5,125 to placebo. 4,907 (with three cases of EV71-associated HFMD and eight cases of EV71-
associated disease) versus 4,939 (with 30 cases of EV71-associated HFMD and 41 cases of EV71-
associated disease) were included in the primary efficacy analysis. Vaccine efficacy was 90.0% 
(95% CI 67.1 – 96.9) against EV71-associated HFMD (p=0·0001) and 80.4% (95% CI 58.2 – 90.8) 
against EV71-associated disease (p<0·0001). Serious adverse events were reported by 62 of 5,117 
(1.2%) participants in the vaccine group versus 75 of 5,123 (1.5%) in the placebo group (p=0·27). 
Adverse events occurred in 3,644 (71.2%) versus 3,603 (70.3%; p=0·33). The authors believe that EV71 
vaccine provides high efficacy, satisfactory safety, and sustained immunogenicity.  
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